• Get a perspective of early-stage development strategy in the area of your choice: veterinary medicinal products, animal nutrition, or medical devices
• Gain clarity around the pre-clinical, clinical and regulatory requirements in the EU and the US market and the process for achieving approval
• Acquire insights on when and how to select the right partner(s) or strategic alliances to accelerate the development of your product
• Highlight the challenges of the economic downturn on clinical studies and discuss potential solutions

Dr Elinor McCartney 

Technical Director at Pen & Tec Consulting

Dr Elinor McCartney is a renowned professional public speaker in the food industry, having presented at various international conferences concerning food and feed law and delivering training courses to large groups of professionals both face to face and online. With over 30 years’ experience in product development, project management and EU regulatory affairs, Elinor can provide strategic advice, regulatory support and tailor-made training materials at any stage of your project: 

• R&D 
• Registration 
• Marketing 
• Labelling & claims 

 Dr Klaus Hellmann 

Chief Veterinary Officer, Argenta 

 In the eighties, Klaus studied veterinary medicine followed by a thesis in applied biochemistry in boar reproduction at the Veterinary School in Hannover, Germany. 

 From 1991 to 1994 Klaus worked at Pfizer Animal Health in Germany on technical, marketing, regulatory requirements including quality, safety and efficacy of VMPs. Since 1995, Klaus is consulting the animal health industry on the development and registration of animal health products and plans, supervises and conducts safety and efficacy studies testing veterinary medicinal products in various animal species. From 1997, as founder, he has been the General Manager of the contract research organisation and regulatory consultancy KLIFOVET, Munich, Germany, one of the leading organisations providing dedicated services to support new product development and registration for animal health products. Since May 2022, he is the Chief Veterinary Officer of KLIFOVET, which is now part of the Argenta Group. He has extensive experience consulting all, multinationals, family businesses and start-ups how to develop animal health products and has led various organisations to successful granting of marketing authorisations for vaccines, biologicals and pharmaceuticals. He also has been responsible on various aspects to maintain marketing authorisations including acting as qualified person and,head of quality control within GMP and qualified person for pharmacovigilance (QPPV) for veterinary medicinal products. 

 Klaus is active in various animal health and veterinary organisations including the Association of Veterinary Consultants (AVC), the European College for Veterinary Pharmacology and Toxicology, the European Board of Veterinary Specialisation (EBVS) for many years, at the same time he has been a member of the American Association of Veterinary Parasitology, American Association of Veterinary Pharmacology and Thereapeutics, European Association of veterinary Pharmacology and Toxicology and World Association of the Advancement of Veterinary Parasitology and selected member of organisation committees of Antimicrobial Agents in Veterinary Medicines since 2014. He has also organised and hosted multiple international conferences and workshops. 

 Multiple scientific publications on antiparasitics, antimicrobials, vaccines, and novel therapies in various animal species, but also on various topics of the regulation, quality and legal requirements on animal health products show his broad spectrum of expertise (www.klifovet.com). 

 Contact: klaus.hellmann@argentaglobal.com, Munich, Germany.

Dr Patxi Sarasola

Managing Director, Ondax Scientific

Dr Patxi Sarasola is a veterinary surgeon with a PhD in veterinary pharmacology. With 30 years experience both in academic research and product development in the animal health industry, he set- up a contract research organization, Ondax Scientific in 2000 which is now part of the Argenta group. Having worked in many therapeutic areas both in livestock and companion animals, his main areas of expertise include clinical development and clinical trials for registration of veterinary pharmaceuticals, biologicals and novel therapies. In addition, he provides strategic development advice to biotechnology and start-ups wishing to develop, register or commercialize their ideas and novel compounds in the animal health arena.

To book the course please follow the link.